Emerging technologies for cancer research: Towards personalized medicine with microfluidic platforms and 3D tumor models
M Turetta, FD Ben, G Brisotto… - Current medicinal …, 2018 - ingentaconnect.com
In the present review, we describe three hot topics in cancer research such as circulating
tumor cells, exosomes, and 3D environment models. The first section is dedicated to …
tumor cells, exosomes, and 3D environment models. The first section is dedicated to …
[HTML][HTML] A p53/miR-30a/ZEB2 axis controls triple negative breast cancer aggressiveness
A di Gennaro, V Damiano, G Brisotto… - Cell Death & …, 2018 - nature.com
Inactivation of p53 contributes significantly to the dismal prognosis of breast tumors, most
notably triple-negative breast cancers (TNBCs). How the relief from p53 tumor suppressive …
notably triple-negative breast cancers (TNBCs). How the relief from p53 tumor suppressive …
Carbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis
E Andreucci, S Peppicelli, F Carta, G Brisotto… - Journal of Molecular …, 2017 - Springer
Among the players of the adaptive response of cancer cells able to promote a resistant and
aggressive phenotype, carbonic anhydrase IX (CAIX) recently has emerged as one of the …
aggressive phenotype, carbonic anhydrase IX (CAIX) recently has emerged as one of the …
IgG antibodies against SARS-CoV-2 decay but persist 4 months after vaccination in a cohort of healthcare workers
G Brisotto, E Muraro, M Montico, C Corso… - Clinica Chimica …, 2021 - Elsevier
Background and aims Monitoring the immune response against SARS-CoV-2 is pivotal in
the evaluation of long-term vaccine efficacy. Immunoglobulin G (IgG) antibodies represent an …
the evaluation of long-term vaccine efficacy. Immunoglobulin G (IgG) antibodies represent an …
[HTML][HTML] Overview of epstein–barr-virus-associated gastric cancer correlated with prognostic classification and development of therapeutic options
V De Re, G Brisotto, O Repetto, M De Zorzi… - International Journal of …, 2020 - mdpi.com
Gastric cancer (GC) is a deadly disease with poor prognosis that is characterized by
heterogeneity. New classifications based on histologic features, genotypes, and molecular …
heterogeneity. New classifications based on histologic features, genotypes, and molecular …
[HTML][HTML] Promising drugs and treatment options for pediatric and adolescent patients with Hodgkin lymphoma
V De Re, O Repetto, L Mussolin, G Brisotto… - Frontiers in Cell and …, 2022 - frontiersin.org
Currently-available therapies for newly-diagnosed pediatric and adolescent patients with
Hodgkin lymphoma result in >95% survival at 5 years. Long-term survivors may suffer from long…
Hodgkin lymphoma result in >95% survival at 5 years. Long-term survivors may suffer from long…
Epigenetic silencing of miR‐200c in breast cancer is associated with aggressiveness and is modulated by ZEB1
V Damiano, G Brisotto, S Borgna… - Genes …, 2017 - Wiley Online Library
Loss of expression of miR‐200 family members has been implicated in cellular plasticity, a
phenomenon that accounts for epithelial‐to‐mesenchymal transition (EMT) and stem‐like …
phenomenon that accounts for epithelial‐to‐mesenchymal transition (EMT) and stem‐like …
[HTML][HTML] Anti-VEGF therapy selects for clones resistant to glucose starvation in ovarian cancer xenografts
…, I Masgras, L Caporali, F Del Ben, G Brisotto… - Journal of Experimental …, 2023 - Springer
Background Genetic and metabolic heterogeneity are well-known features of cancer and
tumors can be viewed as an evolving mix of subclonal populations, subjected to selection …
tumors can be viewed as an evolving mix of subclonal populations, subjected to selection …
[HTML][HTML] Radiation recall dermatitis induced by COVID-19 vaccination in breast cancer patients treated with postoperative radiation therapy
…, A Giroldi, M Marson, G Franchin, E Muraro, G Brisotto… - The Breast, 2022 - Elsevier
Background and purpose: Radiation recall dermatitis is an adverse event predominantly
due to systemic therapy administration after a previous radiation therapy course. Few case …
due to systemic therapy administration after a previous radiation therapy course. Few case …
[HTML][HTML] Clinical relevance of the combined analysis of circulating tumor cells and anti-tumor T-cell immunity in metastatic breast cancer patients
…, S Spazzapan, R Dolcetti, A Steffan, G Brisotto - Frontiers in …, 2022 - frontiersin.org
Background: Metastatic breast cancer (mBC) is a heterogeneous disease with varying
responses to treatments and clinical outcomes, still requiring the identification of reliable …
responses to treatments and clinical outcomes, still requiring the identification of reliable …